Literature DB >> 24474887

Advanced therapy medicinal products - a multiple challenge.

Axel Pruss1, Henk Garritsen2.   

Abstract

Year:  2013        PMID： 24474887      PMCID： PMC3901633          DOI： 10.1159/000357305

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  10 in total

1.  Slight changes in the mechanical stimulation affects osteoblast- and osteoclast-like cells in co-culture.

Authors:  Anke Kadow-Romacker; Georg N Duda; Nicole Bormann; Gerhard Schmidmaier; Britt Wildemann
Journal:  Transfus Med Hemother       Date:  2013-10-27       Impact factor: 3.747

2.  Whither advanced therapy medicinal products?

Authors:  Mark D Smith; Jan C Brune; Britt Wildemann; Axel Pruss
Journal:  Transfus Med Hemother       Date:  2013-11-12       Impact factor: 3.747

3.  Bioactive factors in platelet-rich plasma obtained by apheresis.

Authors:  Jan Philipp Krüger; Undine Freymannx; Samuel Vetterlein; Katja Neumann; Michaela Endres; Christian Kaps
Journal:  Transfus Med Hemother       Date:  2013-10-27       Impact factor: 3.747

4.  Validation of Serological Testing for Anti-Treponema pallidum from Postmortem Blood on the Siemens-BEP(®)-III Automatic System.

Authors:  Ulrich Kalus; Ina Wilkemeyer; Axel Pruss; Gregor Caspari
Journal:  Transfus Med Hemother       Date:  2013-10-17       Impact factor: 3.747

Review 5.  Genetically modified T cells for the treatment of malignant disease.

Authors:  Agnieszka Wieczorek; Lutz Uharek
Journal:  Transfus Med Hemother       Date:  2013-11-29       Impact factor: 3.747

6.  Proteomic analysis of human-derived cell culture supplements.

Authors:  Jasmin Kemptner; Karin Witzeneder; Simone Hennerbichler; Christian Gabriel
Journal:  Transfus Med Hemother       Date:  2013-11-29       Impact factor: 3.747

7.  Human-derived alternatives to fetal bovine serum in cell culture.

Authors:  Karin Witzeneder; Andrea Lindenmair; Christian Gabriel; Katharina Höller; Denise Theiß; Heinz Redl; Simone Hennerbichler
Journal:  Transfus Med Hemother       Date:  2013-11-29       Impact factor: 3.747

Review 8.  European regulatory tools for advanced therapy medicinal products.

Authors:  Egbert Flory; Jens Reinhardt
Journal:  Transfus Med Hemother       Date:  2013-10-28       Impact factor: 3.747

9.  Improvement of contraction force in injured skeletal muscle after autologous mesenchymal stroma cell transplantation is accompanied by slow to fast fiber type shift.

Authors:  Philipp von Roth; Tobias Winkler; Kristina Rechenbach; Piotr Radojewski; Carsten Perka; Georg N Duda
Journal:  Transfus Med Hemother       Date:  2013-10-27       Impact factor: 3.747

10.  Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey.

Authors:  O Noel Gill; Yvonne Spencer; Angela Richard-Loendt; Carole Kelly; Reza Dabaghian; Lynnette Boyes; Jacqueline Linehan; Marion Simmons; Paul Webb; Peter Bellerby; Nick Andrews; David A Hilton; James W Ironside; Jon Beck; Mark Poulter; Simon Mead; Sebastian Brandner
Journal:  BMJ       Date:  2013-10-15
  10 in total
  2 in total

1.  The Authors Reply.

Authors:  James A Hutchinson; Edward K Geissler
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

2.  In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies.

Authors:  Christiane Broichhausen; Paloma Riquelme; Norbert Ahrens; Anja K Wege; Gudrun E Koehl; Hans J Schlitt; Bernhard Banas; Fred Fändrich; Edward K Geissler; James A Hutchinson
Journal:  Mol Ther Methods Clin Dev       Date:  2014-07-16       Impact factor: 6.698
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.